120 related articles for article (PubMed ID: 9638973)
1. CDKN2 (MTS1/p16INK4A) gene alterations in adult T-cell leukemia/lymphoma.
Uchida T; Kinoshita T; Murate T; Saito H; Hotta T
Leuk Lymphoma; 1998 Mar; 29(1-2):27-35. PubMed ID: 9638973
[TBL] [Abstract][Full Text] [Related]
2. CDKN2 (MTS1/p16INK4A) gene alterations in hematological malignancies.
Uchida T; Kinoshita T; Saito H; Hotta T
Leuk Lymphoma; 1997 Feb; 24(5-6):449-61. PubMed ID: 9086436
[TBL] [Abstract][Full Text] [Related]
3. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
Hatta Y; Koeffler HP
Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
[TBL] [Abstract][Full Text] [Related]
4. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B
Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443
[TBL] [Abstract][Full Text] [Related]
5. The CDKN2 gene alterations in various types of adult T-cell leukaemia.
Uchida T; Kinoshita T; Watanabe T; Nagai H; Murate T; Saito H; Hotta T
Br J Haematol; 1996 Sep; 94(4):665-70. PubMed ID: 8826890
[TBL] [Abstract][Full Text] [Related]
6. [Tribulations of the p16/MTS1/CDKN2 tumor gene suppressor: a continuing saga].
Larsen CJ
Bull Cancer; 1997 Apr; 84(4):427-30. PubMed ID: 9238169
[TBL] [Abstract][Full Text] [Related]
7. p16ink4a gene and hematological malignancies.
Quesnel B; Preudhomme C; Fenaux P
Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
[TBL] [Abstract][Full Text] [Related]
8. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
Balázs M; Carroll P; Kerschmann R; Sauter G; Waldman FM
Genes Chromosomes Cancer; 1997 Jun; 19(2):84-9. PubMed ID: 9171998
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the p16INK4A gene in ex vivo acute adult T cell lymphoma/leukemia cells and methylation of the p16INK4A promoter in HTLV type I-infected T cell lines.
Trovato R; Cereseto A; Takemoto S; Gessain A; Watanabe T; Waldmann T; Franchini G
AIDS Res Hum Retroviruses; 2000 May; 16(8):709-13. PubMed ID: 10826477
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
11. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
Fujishita T; Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
[TBL] [Abstract][Full Text] [Related]
12. Growth arrest and suppression of tumorigenicity of bladder-carcinoma cell lines induced by the P16/CDKN2 (p16INK4A, MTS1) gene and other loci on human chromosome 9.
Wu Q; Possati L; Montesi M; Gualandi F; Rimessi P; Morelli C; Trabanelli C; Barbanti-Brodano G
Int J Cancer; 1996 Mar; 65(6):840-6. PubMed ID: 8631601
[TBL] [Abstract][Full Text] [Related]
13. Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma.
Uenogawa K; Hatta Y; Arima N; Hayakawa S; Sawada U; Aizawa S; Yamamoto T; Takeuchi J
Int J Mol Med; 2011 Nov; 28(5):835-9. PubMed ID: 21785817
[TBL] [Abstract][Full Text] [Related]
14. [Genetic analysis and its clinical implication in adult T-cell leukemia/lymphoma].
Kogure Y; Kataoka K
Rinsho Ketsueki; 2018; 59(10):2127-2135. PubMed ID: 30305518
[TBL] [Abstract][Full Text] [Related]
15. Deletion or lack of expression of CDKN2 (CDK4I/MTS1/INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells.
Jagasia AA; Sher DA; Le Moine PJ; Kim DH; Moldwin RL; Smith SD; Diaz MO
Leukemia; 1996 Apr; 10(4):624-8. PubMed ID: 8618438
[TBL] [Abstract][Full Text] [Related]
16. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4.
Suzuki T; Kitao S; Matsushime H; Yoshida M
EMBO J; 1996 Apr; 15(7):1607-14. PubMed ID: 8612584
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the dual coding capacity of the p16INK4a/MTS1/CDKN2 locus to human malignancies.
Larsen CJ
Prog Cell Cycle Res; 1997; 3():109-24. PubMed ID: 9552410
[TBL] [Abstract][Full Text] [Related]
18. Alterations of CDKN2 gene structure in childhood acute lymphoblastic leukemia: mutations of CDKN2 are observed preferentially in T lineage.
Nakao M; Yokota S; Kaneko H; Seriu T; Koizumi S; Takaue Y; Fujimoto T; Misawa S
Leukemia; 1996 Feb; 10(2):249-54. PubMed ID: 8637233
[TBL] [Abstract][Full Text] [Related]
19. [Molecullar structure and function of the p16/INK4a/CDKN2/MTS1 and the INK4 family, and their association with carcinogenesis].
Okamoto A; Tanaka T
Nihon Rinsho; 1996 Apr; 54(4):1037-42. PubMed ID: 8920670
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
